AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$CL

1 Dividend King to Buy Before the New Year and Hold Forever

Colgate-Palmolive (CL) surged 12.3% in October, outperforming its peers and the sector ETF. The company reported 3% EPS growth and 3.6% organic sales growth in Q3, raising its full-year revenue guidance to 4-5%. It is considered a strong long-term investment due to its 63-year dividend-hiking streak and defensive stock properties.

Original reporting
finance.yahoo.com
Published Nov 4, 2026, 5:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 5:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
1 Dividend King to Buy Before the New Year and Hold Forever — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

Guidance tightening and steady dividend growth reinforce the stock's defensive narrative but offer limited upside.

02

Market read

Reinforces defensive positioning in a volatile market; modest impact on broader indices.

03

What to watch

Potential brand divestitures (Irish Spring, Speed Stick) could unlock cash and improve returns if executed.

Relevance 4/10Novelty 4/10Timing: before year‑end 2026

Background

The article frames Colgate-Palmolive as a long‑term dividend king amid a market rotation from AI‑heavy tech to defensive consumer staples.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

Colgate-Palmolive reported Q3 EPS up 3% and narrowed full-year revenue guidance to 4-5% from 2-6%, a fresh guidance update.

Expected impact

limited upside as investors price in modest growth; potential pressure if expectations were higher.

Evidence & confidence

The new guidance is modest and aligns with defensive positioning; no catalyst for a sharp move.

Market effects

Sector

Highlights continued rotation into consumer staples amid AI‑related tech weakness.

Regional

U.S. market focus on defensive stocks; limited global ripple.

Global

Modest, as the story is specific to a large U.S. consumer staple.

Counterpoint

What could challenge this read

The modest guidance may signal slowing momentum; investors could favor higher‑growth peers.

Key entities

  • Company
    Colgate-Palmolive

    U.S. consumer‑staples firm and Dividend King.

Read at source← All news

Related articles

$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

investing.com
$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

investing.com
$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

investing.com
$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

finance.yahoo.com
$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

finance.yahoo.com
$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.

finance.yahoo.com